Potential Impact of Sclerocarya birrea on Cardiovascular Health and Related Risk Factors: Review of Existing Evidence
Antioxidants · 2025-08-14 · 14 (8) · 997
DOI: 10.3390/antiox14080997 ↗At a glance
Übersichtsarbeit in Antioxidants, published online on 2025-08-14. Written by Given R Mashaba and 2 co-authors. Institution: DIMAMO Population Health Research Centre, University of Limpopo, Sovenga 0727, South Africa. Cited 1 times so far (Crossref); 60 references. The full text is freely available (open access, CC BY 4.0). Funded by: South African Population Research Infrastructure Network (SAPRIN).
Abstract (original language)
There is increasing use of modern medicine globally to manage cardiovascular diseases (CVDs). However, many people, especially in low-to-middle-income countries, still rely on traditional medicinal plants for their daily health needs. However, limited studies have explored the use of these remedies. Therefore, this narrative review aimed to evaluate the potential of Sclerocarya birrea (S. birrea) in managing diabetes, dyslipidemia, inflammation, and hypertension, including its effects on oxidative stress. This study reviewed evidence from PubMed, Web of Science, and ResearchGate, published in these databases up to 30 April 2025. The evidence showed that S. birrea had the potential to preserve cardiometabolic health and reduce CVD-associated risk factors. Notably, S. birrea improved glucose metabolism, inflammation, hypertension, and oxidative stress. This plant exhibits antihyperglycemic effects by activating adenosine monophosphate-activated protein kinase (AMPK) and inhibiting gluconeogenesis and the activities of carbohydrase. It also ameliorates dyslipidemia by modulating the activities of peroxisome proliferator-activated receptor alpha (PPARα) and increasing fatty acid oxidation. The anti-inflammatory potential of S. birrea is modulated by the activation of PPARα, which inhibits nuclear factor kappa beta (NF-κβ) and decreases the production of inflammatory cytokines. Its antioxidant property is attributed to its ability to increase antioxidant enzymes like catalase (CAT), superoxide dismutase (SOD), and glutathione (GSH), which are known to counteract oxidative damage. However, it is important to note that different parts of the plant had varying impacts on CVD risk factors, depending on whether the study was conducted preclinically or clinically. Therefore, its extract should be explored as a potential remedy for the management of CVD risk factors, especially in areas where access to healthcare is limited.
Subjects
Author keywords
Authors and institutions
- DIMAMO Population Health Research Centre, University of Limpopo, Sovenga 0727, South Africa.
- Department of Life and Consumer Sciences, College of Agriculture and Environmental Sciences, University of South Africa, Roodepoort 1710, South Africa.
ORCID profiles: Kabelo Mokgalaboni
Funding
- South African Population Research Infrastructure Network (SAPRIN)
Cite
APA
Mashaba, G. R., Mokgalaboni, K., & Lebelo, S. L. (2025). Potential Impact of Sclerocarya birrea on Cardiovascular Health and Related Risk Factors: Review of Existing Evidence. Antioxidants, 14(8), 997. https://doi.org/10.3390/antiox14080997
Vancouver
Mashaba GR, Mokgalaboni K, Lebelo SL. Potential Impact of Sclerocarya birrea on Cardiovascular Health and Related Risk Factors: Review of Existing Evidence. Antioxidants. 2025;14(8):997. doi:10.3390/antiox14080997
BibTeX
@article{Mashaba2025,
author = {Mashaba, Given R and Mokgalaboni, Kabelo and Lebelo, Sogolo L},
title = {Potential Impact of Sclerocarya birrea on Cardiovascular Health and Related Risk Factors: Review of Existing Evidence},
journal = {Antioxidants},
year = {2025},
volume = {14},
number = {8},
pages = {997},
doi = {10.3390/antiox14080997}
}
EUVIMED